ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,459,938, issued on Nov. 4, was assigned to Beth Israel Deaconess Medical Center Inc. (Boston).
"ORAI channel inhibitors" was invented by Lijun Sun (Harvard, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present application in one embodiment provides a compound of Formula (I)or a pharmaceutically acceptable salt thereof, wherein X1, X2, X3, X4, X5, X6, Y1, Y2, Y3, R7, R8, R9, R10, RA, RB, W and Cy1 are as described herein. Pharmaceutical compositions containing these compounds, and methods of using these compounds for treating cancer, autoimmune diseases, and inflammatory diseases are also provided."
The patent was filed on March 3, 2020, unde...